论文部分内容阅读
目的观察痰热清注射液治疗小儿毛细支气管炎的临床疗效。方法将住院治疗的毛细支气管炎患儿84例随机分为两组,对照组42例给予抗病毒、抗炎、止咳祛痰等综合治疗,治疗组42例在此基础上加用痰热清注射液静脉滴注,观察两组患儿的临床症状、体征及平均住院时间,并对其疗效进行评价。结果治疗组显效35例,好转5例,无效2例,总有效率95.2%;对照组显效30例,好转6例,无效6例,总有效率85.7%。治疗组的临床症状、体征消失时间及平均住院时间明显短于对照组,两组比较差异有统计学意义(P<0.05)。结论痰热清注射液治疗小儿毛细支气管炎能及时控制症状、减少肺部体征、缩短疗程,且不良反应小,值得临床推广。
Objective To observe the clinical efficacy of Tanreqing Injection in treating children with bronchiolitis. Methods Eighty-four children with bronchiolitis admitted to hospital were randomly divided into two groups. The control group received 42 cases of combined treatment of anti-virus, anti-inflammatory, cough and expectorant. 42 cases of treatment group were treated with Tanreqing injection Liquid intravenous infusion, the clinical symptoms and signs of two groups were observed and the average hospital stay, and evaluate its efficacy. Results In the treatment group, 35 cases were markedly improved, 5 cases were improved, 2 cases were ineffective, and the total effective rate was 95.2%. In the control group, 30 cases were markedly improved, 6 cases improved, 6 cases were ineffective, and the total effective rate was 85.7%. Clinical symptoms, signs of disappearance of the treatment group and the average length of stay in the treatment group was significantly shorter than the control group, the difference between the two groups was statistically significant (P <0.05). Conclusion Tanreqing injection for the treatment of children with bronchiolitis can timely control the symptoms, reduce signs of the lungs, shorten the course of treatment, and the adverse reactions are small, worthy of clinical promotion.